Holdings of First Trust NYSE Arca Biotechnology Index Fund
First Trust Exchange-Traded Fund · Original filing · Compare with another fund · Report an error
- Net assets
- 2.8B $ including 2.8B $ in equities, 100.0 %
- Positions
- 30 in 5 countries
- Top ten
- 43.2 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Corcept Therapeutics Inc | 1,810,937 | 157.5M $ | 5.60 % |
| 2 | NeoGenomics Inc | 9,869,496 | 144M $ | 5.12 % |
| 3 | Veracyte Inc | 2,441,185 | 143.4M $ | 5.10 % |
| 4 | Bruker Corp | 2,019,057 | 121.5M $ | 4.32 % |
| 5 | Alkermes PLC | 2,275,074 | 119.2M $ | 4.24 % |
| 6 | Illumina Inc | 627,605 | 110.4M $ | 3.92 % |
| 7 | Krystal Biotech Inc | 293,036 | 108.9M $ | 3.87 % |
| 8 | NATERA INC | 393,185 | 106.7M $ | 3.79 % |
| 9 | Axsome Therapeutics Inc | 426,122 | 104.3M $ | 3.71 % |
| 10 | Neurocrine Biosciences Inc | 588,847 | 99.2M $ | 3.53 % |
| 11 | Bio-Techne Corp | 1,366,518 | 96.5M $ | 3.43 % |
| 12 | Arrowhead Pharmaceuticals Inc | 1,165,127 | 95M $ | 3.38 % |
| 13 | Biogen Inc | 438,784 | 94.8M $ | 3.37 % |
| 14 | Exelixis Inc | 1,714,400 | 93.3M $ | 3.32 % |
| 15 | Incyte Corp | 790,013 | 89.6M $ | 3.18 % |
| 16 | Argenx SE | 94,913 | 88.1M $ | 3.13 % |
| 17 | Halozyme Therapeutics Inc | 1,119,086 | 87.6M $ | 3.11 % |
| 18 | Vertex Pharmaceuticals Inc | 173,968 | 86.4M $ | 3.07 % |
| 19 | Repligen Corp | 631,943 | 86.2M $ | 3.07 % |
| 20 | BioMarin Pharmaceutical Inc | 1,391,830 | 79.6M $ | 2.83 % |
| 21 | Amgen Inc | 216,227 | 78.3M $ | 2.78 % |
| 22 | BioNTech SE | 794,727 | 73.9M $ | 2.63 % |
| 23 | Genmab A/S | 2,686,600 | 73.8M $ | 2.62 % |
| 24 | United Therapeutics Corp | 132,748 | 71.9M $ | 2.56 % |
| 25 | ALNYLAM PHARMACEUTICALS INC | 235,602 | 70.9M $ | 2.52 % |
| 26 | BEONE MEDICINES LTD | 245,095 | 69.8M $ | 2.48 % |
| 27 | Gilead Sciences Inc | 545,899 | 69M $ | 2.45 % |
| 28 | ADMA Biologics Inc | 7,823,567 | 65.5M $ | 2.33 % |
| 29 | SAREPTA THERAPEUTICS INC | 3,583,400 | 64.4M $ | 2.29 % |
| 30 | Regeneron Pharmaceuticals Inc | 101,350 | 63.2M $ | 2.25 % |
Sector breakdown
- Health care 33.0 %
- Unattributed 67.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 87.4 %
- Ireland 4.2 %
- Netherlands 3.1 %
- Germany 2.6 %
- Denmark 2.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 26 | 2.5B $ | 87.38 % |
| 2 | Ireland | 1 | 119.2M $ | 4.24 % |
| 3 | Netherlands | 1 | 88.1M $ | 3.13 % |
| 4 | Germany | 1 | 73.9M $ | 2.63 % |
| 5 | Denmark | 1 | 73.8M $ | 2.62 % |
Cite this page
Titelia. "Holdings of First Trust NYSE Arca Biotechnology Index Fund". https://titelia.com/en/funds/S000012478